VLP Biotech, Inc.
San Diego, CA
- UEI
- JPNRGENTXC35
- CAGE
- 4AX99
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 3030 Bunker Hill St #117d, San Diego, CA 92109, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
Latest 5 listed here. See the rest on GovTribe.
SBA capabilities narrative
VLP Biotech development of epitope-focused vaccines. Our technology enables elicitation of robust antibody and CD4 T cell responses to defined protein regions. Our technology is suited for carbohydrate or other target conjugation.
Quick answers
Is VLP Biotech, Inc. registered in SAM.gov?
Yes. VLP Biotech, Inc.'s SAM.gov registration is active through January 8, 2027.
What is VLP Biotech, Inc.'s most recent federal award?
VLP Biotech, Inc.'s most recent federal grant award is An epitope-focused nanoparticle vaccine for anthrax (R44AI142939), from National Institute of Allergy and Infectious Diseases (NIH), on May 1, 2019.
On GovTribe
See VLP Biotech, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors